小肠切除术后患者血浆中25-羟维生素D水平及肠道吸收情况
Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection.
作者信息
Compston J E, Creamer B
出版信息
Gut. 1977 Mar;18(3):171-5. doi: 10.1136/gut.18.3.171.
Abstract
Plasma levels of 25-hydroxyvitamin D (25-OHD) were found to be significantly reduced in a group of patients with small bowel resection when compared with normal controls. Plasma levels of 25-OHD after an oral dose of 25-hydroxyvitamin D3 (25-ohd3) were also reduced in the patient group. Dietary intake of vitamin D tended to be low in many patients, but seasonal variation of plasma 25-OHD levels indicated normal exposure to sunlight in most of the patients studied. It is suggested that these studies provide some evidence for malabsorption of 25-OHD after small bowel resection, which, it is postulated, may be due to interruption of the enterohepatic circulation of bile acids and of 25-OHD. These factors may contribute towards the low plasma levels of 25-OHD found in the patient group.
摘要
与正常对照组相比，一组小肠切除患者的血浆25-羟维生素D（25-OHD）水平显著降低。患者组口服一剂25-羟维生素D3（25-ohd3）后的血浆25-OHD水平也降低。许多患者的维生素D膳食摄入量往往较低，但血浆25-OHD水平的季节性变化表明，大多数研究对象的阳光照射正常。这些研究表明，小肠切除术后25-OHD吸收不良存在一些证据，据推测，这可能是由于胆汁酸和25-OHD的肠肝循环中断所致。这些因素可能导致患者组血浆25-OHD水平较低。
相似文献
1
Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection.小肠切除术后患者血浆中25-羟维生素D水平及肠道吸收情况
Gut. 1977 Mar;18(3):171-5. doi: 10.1136/gut.18.3.171.
2
Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis.原发性胆汁性肝硬化中25-羟维生素D的肠道吸收与骨软化症
Lancet. 1977 Apr 2;1(8014):721-4. doi: 10.1016/s0140-6736(77)92167-5.
3
The contribution of dietary vitamin D and sunlight to the plasma 25-hydroxyvitamin D in the elderly.膳食维生素D和阳光对老年人血浆25-羟基维生素D水平的作用。
Hum Nutr Clin Nutr. 1984 May;38(3):191-4.
4
25-Hydroxycholecalciferol absorption in steatorrhoea and postgastrectomy osteomalacia.脂肪泻和胃切除术后骨软化症中25-羟基胆钙化醇的吸收情况
Br Med J. 1977 May 21;1(6072):1310-2. doi: 10.1136/bmj.1.6072.1310.
5
Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population.丹麦人群血清中25-羟基维生素D的测量及其与日照、年龄和维生素D摄入量的关系。
Scand J Clin Lab Invest. 1979 Feb;39(1):23-30. doi: 10.3109/00365517909104935.
6
Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.25-羟维生素D2/D3和1α,25-二羟维生素D2/D3的放射性配体受体测定
J Clin Invest. 1976 Jul;58(1):61-70. doi: 10.1172/JCI108459.
7
25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol.接受高剂量麦角钙化醇和胆钙化醇治疗患者的25-羟基维生素D水平
J Clin Pathol. 1977 Feb;30(2):144-50. doi: 10.1136/jcp.30.2.144.
8
Vitamin D metabolism in the hooded seal (Cystophora cristata).冠海豹（Cystophora cristata）的维生素D代谢
J Nutr. 1988 Mar;118(3):332-41. doi: 10.1093/jn/118.3.332.
9
25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency.克罗恩病和胰腺功能不全患者对25-羟基维生素D的吸收情况
Wien Klin Wochenschr. 1997 Sep 19;109(17):678-82.
10
Faecal tritium excretion after intravenous administration of 3H-25-hydroxyvitamin D3 in control subjects and in patients with malabsorption.在对照受试者和吸收不良患者中静脉注射³H-25-羟基维生素D3后的粪便氚排泄情况。
Gut. 1982 Apr;23(4):310-5. doi: 10.1136/gut.23.4.310.
引用本文的文献
1
Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease-Do We Already Know Everything?炎症性肠病患者骨质疏松的危险因素——我们已经了解所有的内容了吗？
Nutrients. 2023 Feb 24;15(5):1151. doi: 10.3390/nu15051151.
2
Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease.炎症性肠病患者的骨代谢改变
J Clin Med. 2022 Jul 16;11(14):4138. doi: 10.3390/jcm11144138.
3
HIGH PREVALENCE OF UNTREATED AND UNDERTREATED VITAMIN D DEFICIENCY AND INSUFFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.炎症性肠病患者中未经治疗和治疗不足的维生素D缺乏及不足的高患病率。
Acta Clin Croat. 2020 Mar;59(1):109-118. doi: 10.20471/acc.2020.59.01.13.
4
Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective.炎症性肠病与健康中维生素D缺乏的预测因素：密西西比州的视角
World J Gastroenterol. 2017 Jan 28;23(4):638-645. doi: 10.3748/wjg.v23.i4.638.
5
A randomized two way cross over study for comparison of absorption of vitamin D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption.一项比较维生素 D3 口腔喷雾和软胶囊制剂在健康受试者和肠道吸收不良患者中吸收情况的随机双盲交叉研究。
Nutr J. 2015 Oct 29;14:114. doi: 10.1186/s12937-015-0105-1.
6
The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).维生素D代谢物的临床应用及其潜在发展：来自欧洲骨质疏松症与骨关节炎临床与经济学会（ESCEO）和国际骨质疏松症基金会（IOF）的立场声明。
Endocrine. 2015 Sep;50(1):12-26. doi: 10.1007/s12020-015-0606-x. Epub 2015 May 1.
7
The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease.疾病的早发可能是炎症性肠病患者骨密度降低的一个风险因素。
Clin Endosc. 2013 Jan;46(1):71-6. doi: 10.5946/ce.2013.46.1.71. Epub 2013 Jan 31.
8
Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults.健康成年人口服 25-羟维生素 D2 后的血浆出现和消失。
Br J Nutr. 2012 Apr;107(8):1128-37. doi: 10.1017/S0007114511004132. Epub 2011 Sep 7.
9
Clinical relevance of changes in bone metabolism in inflammatory bowel disease.炎症性肠病中骨代谢变化的临床意义。
World J Gastroenterol. 2010 Nov 28;16(44):5536-42. doi: 10.3748/wjg.v16.i44.5536.
10
Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomy.甲状旁腺切除术后长期血液透析患者并发短肠综合征导致严重佝偻病。
J Bone Miner Metab. 2011 Mar;29(2):245-50. doi: 10.1007/s00774-010-0232-x. Epub 2010 Nov 12.
本文引用的文献
1
METABOLISM OF VITAMIN D. I. PREPARATION OF RADIOACTIVE VITAMIN D AND ITS INTESTINAL ABSORPTION IN THE RAT.维生素D的代谢。I. 放射性维生素D的制备及其在大鼠肠道中的吸收
J Clin Invest. 1964 May;43(5):787-96. doi: 10.1172/JCI104965.
2
Seasonal changes in human plasma levels of 25-hydroxyvitamin D.人体血浆中25-羟基维生素D水平的季节性变化。
Nature. 1974 Feb 22;247(5442):563-5. doi: 10.1038/247563a0.
3
Competitive protein-binding assay for 25-hydroxycholecalciferol.25-羟胆钙化醇的竞争性蛋白结合测定法。
Clin Sci Mol Med. 1974 Feb;46(2):231-40. doi: 10.1042/cs0460231.
4
Competitive protein-binding radioassay for 25-hydroxycholecalciferol.25-羟基胆钙化醇的竞争性蛋白结合放射分析
J Clin Endocrinol Metab. 1971 Dec;33(6):992-5. doi: 10.1210/jcem-33-6-992.
5
"Activation" of vitamin D by the liver.肝脏对维生素D的“激活”。
J Clin Invest. 1969 Nov;48(11):2032-7. doi: 10.1172/JCI106168.
6
Intestinal absorption and esterification of vitamin D3-1,2-3H in man.
Acta Chem Scand. 1967;21(6):1662-3. doi: 10.3891/acta.chem.scand.21-1662.
7
Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine.人体中维生素D3-3H的代谢：在血液、胆汁、粪便和尿液中的分布。
J Clin Invest. 1967 Jun;46(6):983-92. doi: 10.1172/JCI105605.
8
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.正常对照者和肠道吸收不良患者对维生素D3-3H的吸收情况。
J Clin Invest. 1966 Jan;45(1):94-102. doi: 10.1172/JCI105327.
9
Intestinal absorption of 25-hydroxycholecalciferol.
Lancet. 1974 Jul 20;2(7873):121-3. doi: 10.1016/s0140-6736(74)91553-0.
10
Seasonal variations in serum 25-hydroxycholecalciferol in healthy people.健康人群血清25-羟基胆钙化醇的季节性变化
Lancet. 1974 Mar 30;1(7857):536-8. doi: 10.1016/s0140-6736(74)92717-2.
Zotero 插件